查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1512707

医疗用抛弃式市场:市场规模&预测，2024年～2032年

Medical Disposable Market : Market Size & Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 110 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

根据 Polaris Market Research 发布的一项新研究，到 2032 年，一次性医疗用品市场预计将达到 21,428 亿美元以上。 2023年，药物输送在全球医疗一次性用品产业中占据主导地位。预计到 2023 年，亚太地区将成为全球市场收入的主要贡献者。医院、门诊设施和其他医疗保健提供者的一次性医疗用品势头强劲。医疗一次性用品市场主要是由老年人口的增加、限制感染源的需求不断增加、更好的性能、成本可靠性、保质期和材料推动的。可重复使用的器具有多种类型，被认为相对便宜，全球主要参与者增加产量也可能影响未来几年的市场成长。

技术先进产品的增加和持续的研发也将推动市场成长。此外，提高患者对使用一次性医疗设备的认识也将推动未来几年的市场成长。此外，全球慢性病盛行率的不断上升也可能推动未来几年的市场成长。

依产品类型，一次性医疗用品市场分为伤口处理、药物传输、透析、非织造失禁、呼吸用品、诊断和实验室以及灭菌。同样，依原料划分，市场分为纸张和纸板、塑胶树脂、不织布、金属、玻璃和橡胶。塑胶树脂是成长最快的领域，因为它们有多种应用。医疗一次性设备的最终使用者包括医院、门诊/初级保健机构和家庭保健机构。

北美在 2023 年是一次性医疗用品市场收入最高的地区，预计在预测期内将成为全球领先地区。对医疗保健设施的需求增加、老年人口不断增长以及美国和加拿大主要参与者的持续併购。亚太地区也将在未来几年推动市场成长。该地区国家的新兴市场开发将是预测期内推动市场成长的关键因素。

医疗一次性用品市场的主要参与者包括Johnson &Johnson Services, Inc.，3M，Abbott Laboratories，Medtronic Plc.，B． Braun Melsungen AG，Bayer AG，Smith and Nephew Plc.，Medline Industries, Inc.，Cardinal Health，Becton, Dickinson &Company等。为了与产业各公司，消费者的需求和要求的高涨对应，签订其他公司的合作和伙伴关係契约开发·发售着新产品。

目录

第1章 概要与范围

  • 调查目标和范围
  • 调查的前提条件
  • 调查手法
  • 要点
  • 利害关係者

第2章 摘要整理

第3章 医疗用抛弃式的市场分析

  • 医疗用抛弃式-产业概述
  • 医疗用抛弃式-生态系统分析
  • 医疗用抛弃式市场动态
    • 医疗用抛弃式-市场要点
      • 医疗用抛弃式的市场推动要素分析
      • 医疗用抛弃式市场阻碍因素/课题分析
      • 医疗用抛弃式的市场机会分析
  • 产业分析- 波特的五力分析
    • 供应商谈判力
    • 买方议价能力
    • 替代品的威胁
    • 新加入厂商的威胁
    • 竞争的程度
  • 医疗用抛弃式市场PEST分析
  • 医疗用抛弃式市场价值链分析
  • 医疗用抛弃式趋势
  • 竞争排行榜分析

第4章 医疗用抛弃式的市场规模与预测:各治疗类型，2019年～2032年

  • 主要调查结果
  • 创伤管理
  • 药物输送
  • 透析
  • Nonwoven Incontinence
  • 呼吸系统用品
  • 诊断及检验
  • 杀菌

第5章 医疗用抛弃式的市场规模与预测:各原材料类型，2019年～2032年

  • 主要调查结果
  • 纸张及厚纸板
  • 塑胶树脂
  • 不织布材料
  • 金属
  • 玻璃
  • 橡胶

第6章 医疗用抛弃式的市场规模与预测:各最终用途，2019年～2032年

  • 主要调查结果
  • 医院
  • 门诊病人/基层护理设施
  • 家庭医疗保健

第7章 医疗用抛弃式的市场规模与预测:各地区，2019年～2032年

  • 主要调查结果
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 新加坡
    • 马来西亚
    • 澳洲
    • 其他亚太地区
  • 南美
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他的南美
  • 中东·非洲

第8章 企业简介

  • Johnson & Johnson Services, Inc.
  • 3M
  • Abbott Laboratories.
  • Braun Melsungen AG
  • Bayer AG
  • Smith and Nephew Plc
  • Medline Industries, Inc.
  • Cardinal Health.
  • Becton, Dickinson & Company
  • Medtronic Plc.gk
简介目录
Product Code: PM1572

The medical disposable market is anticipated to reach over USD 2142.80 billion by 2032 according to a new research published by Polaris Market Research. In 2023, the drug delivery dominated the worldwide medical disposable industry. Asia-Pacific is anticipated to be the leading contributor to the global market revenue in 2023. The upward momentum of medical disposable in the hospitals, outpatient facility and other healthcare providers. The medical disposable market is primarily driven by increasing number of elderly populations, increasing need to limit the causes of infection, better performance, cost reliability, shelf life, and material. The reusable devices are considered to be relatively inexpensive in many different types, and increasing volume of production by the key players globally would also influence the market growth in the coming years.

Increasing number of technologically advanced products, and continuous research and development to also drive the market growth. Furthermore, increasing awareness in the patients for the use of medical disposable devices to also boost the market growth in the coming years. Also, increasing number of chronic diseases across the globe would also boost the market growth in the coming years.

Based on the product type the medical disposable market is segmented as Wound Management, Drug Delivery, Dialysis, Nonwoven Incontinence, Respiratory Supplies, Diagnostic and Laboratory, and Sterilization. Similarly, on the basis of raw material, the market is segmented as Paper and Paperboard, Plastic Resin, Nonwoven Material, Metals, Glass, and Rubber. Plastic Resin is expected to be the fastest growing segment owning to its various application. End user for the medical disposable devices include Hospitals, Outpatient/Primary Care Facilities, and Home Healthcare.

North America generated the highest revenue in the Medical Disposable market in 2023, and is expected to be the leading region globally during the forecast period. Increasing demand healthcare facilities, increasing number of geriatric populations, and continuous mergers and acquisitions of the key players in the U.S. and Canada. Asia Pacific to also boost the market growth in coming years. The developing healthcare infrastructure of the countries in this region to be the major factor promoting the growth of this market during the forecast period.

The key players operating in the Medical Disposable market include Johnson & Johnson Services, Inc., 3M, Abbott Laboratories, Medtronic Plc., B. Braun Melsungen AG, Bayer AG, Smith and Nephew Plc., Medline Industries, Inc., Cardinal Health, and Becton, Dickinson & Company. The industry participants launch novel products with collaboration and partnership agreements with other companies to innovate and launch new products to meet the increasing needs and requirements of consumers.

Table of Contents

1. Overview and Scope

  • 1.1. Research goal & scope
  • 1.2. Research assumptions
  • 1.3. Research Methodology
    • 1.3.1. Primary data sources
    • 1.3.2. Secondary data sources
  • 1.4. Key take-away
  • 1.5. Stakeholders

2. Executive Summary

  • 2.1. Market Definition
  • 2.2. Market Segmentation

3. Medical Disposable Market Insights

  • 3.1. Medical disposable - Industry snapshot
  • 3.2. Medical disposable - Ecosystem analysis
  • 3.3. Medical disposable Market Dynamics
    • 3.3.1. Medical disposable - Market Forces
      • 3.3.1.1. Medical disposable Market Driver Analysis
      • 3.3.1.2. Medical disposable Market Restraint/Challenges analysis
      • 3.3.1.3. Medical disposable Market Opportunity Analysis
  • 3.4. Industry analysis - Porter's five force
    • 3.4.1. Bargaining power of supplier
    • 3.4.2. Bargaining power of buyer
    • 3.4.3. Threat of substitute
    • 3.4.4. Threat of new entrant
    • 3.4.5. Degree of competition
  • 3.5. Medical disposable Market PEST Analysis
  • 3.6. Medical disposable Market Value Chain Analysis
  • 3.7. Medical disposable Industry Trends
  • 3.8. Competitive Ranking Analysis

4. Medical Disposable Market Size and Forecast by Treatment Type, 2019-2032

  • 4.1. Key Findings
  • 4.2. Wound Management
  • 4.3. Drug Delivery
  • 4.4. Dialysis
  • 4.5. Nonwoven Incontinence
  • 4.6. Respiratory Supplies
  • 4.7. Diagnostic and Laboratory
  • 4.8. Sterilization

5. Medical Disposable Market Size and Forecast by Raw Material Type, 2019-2032

  • 5.1. Key Findings
  • 5.2. Paper and Paperboard
  • 5.3. Plastic Resin
  • 5.4. Nonwoven Material
  • 5.5. Metals
  • 5.6. Glass
  • 5.7. Rubber

6. Medical Disposable Market Size and Forecast by End Use, 2019-2032

  • 6.1. Key Findings
  • 6.2. Hospitals
  • 6.3. Outpatient/Primary Care Facilities
  • 6.4. Home Healthcare

7. Medical Disposable Market Size and Forecast by Region, 2019-2032

  • 7.1. Key Findings
  • 7.2. North America
    • 7.2.1. U. S.
    • 7.2.2. Canada
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. UK
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe
  • 7.4. Asia-Pacific
    • 7.4.1. China
    • 7.4.2. India
    • 7.4.3. Japan
    • 7.4.4. Singapore
    • 7.4.5. Malaysia
    • 7.4.6. Australia
    • 7.4.7. Rest of Asia-Pacific
  • 7.5. Latin America
    • 7.5.1. Mexico
    • 7.5.2. Brazil
    • 7.5.3. Argentina
    • 7.5.4. Rest of LATAM
  • 7.6. Middle East & Africa

8. Company Profiles

  • 8.1. Johnson & Johnson Services, Inc.
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Developments
  • 8.2. 3M
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Developments
  • 8.3. Abbott Laboratories.
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Developments
  • 8.4. Braun Melsungen AG
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Developments
  • 8.5. Bayer AG
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Developments
  • 8.6. Smith and Nephew Plc
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Developments
  • 8.7. Medline Industries, Inc.
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Developments
  • 8.8. Cardinal Health.
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Developments
  • 8.9. Becton, Dickinson & Company
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Developments
  • 8.10. Medtronic Plc.gk
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Developments